Alberta Health Services

Running trials

• Recruiting

  Routine vs On-demand ECMO for Lung Transplantation

  NCT06615492· Centre hospitalier de l'Université de Montréal (CHUM)· Source

• Active, not recruiting

  Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

  NCT05782907· Phase 3· AbbVie· Source

• Recruiting

  CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes

  NCT05754567· University of Manitoba· Source

• Recruiting

  Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

  NCT05114096· Phase 4· McMaster University· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT04586426· Phase 1/2· Janssen Research & Development, LLC· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Source

• Recruiting

  Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.

  NCT03595267· University of Manitoba· Source

• Active, not recruiting

  Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

  NCT03485378· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

• Active, not recruiting

  A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

  NCT02130362· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Asthma1 recruiting
• COPD1 recruiting
• High blood pressure1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

  NCT06003114· Pfizer· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· Phase 3· Actelion· Source

• Terminated

  WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

  NCT03297359· Phase 2· Ottawa Hospital Research Institute· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

  NCT03201965· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

  NCT02601950· Phase 2· Epizyme, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cystic fibrosis14 works · 0 trials